UBS Group
RNXT icon

UBS Group’s RenovoRx RNXT Stock Holding History

UBS Group’s Portfolio RNXT Stock Details RNXT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.4K Buy
20,820
+17,482
+524% +$15.9K ﹤0.01% 8157
2026
Q1 		$3.37K Buy
3,338
+1,059
+46% +$1.02K ﹤0.01% 9096
2025
Q4 		$1.92K Buy
2,279
+1,608
+240% +$1.61K ﹤0.01% 9437
2025
Q3 		$852 Sell
671
-29,338
-98% -$34.9K ﹤0.01% 9517
2025
Q2 		$39.5K Sell
30,009
-36,723
-55% -$41.8K ﹤0.01% 7967
2025
Q1 		$66.1K Buy
66,732
+54,466
+444% +$63.4K ﹤0.01% 7371
2024
Q4 		$15.8K Buy
12,266
+10,030
+449% +$11.4K ﹤0.01% 8028
2024
Q3 		$2.37K Buy
2,236
+931
+71% +$1.04K ﹤0.01% 8447
2024
Q2 		$1.48K Buy
+1,305
New +$1.6K ﹤0.01% 8571
2023
Q2 		– Sell
-2,530
Closed -$8.82K – 9525
2023
Q1 		$8.82K Buy
+2,530
New +$8.91K ﹤0.01% 7694
2022
Q4 		– Sell
-1,256
Closed -$3K – 11073
2022
Q3 		$3K Sell
1,256
-4,961
-80% -$10.8K ﹤0.01% 9571
2022
Q2 		$12K Buy
+6,217
New +$12.7K ﹤0.01% 7677
2022
Q1 		– Sell
-4,512
Closed -$22K – 10805
2021
Q4 		$22K Buy
+4,512
New +$26.8K ﹤0.01% 7741

Other funds holding RNXT

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WANY
Wealthspire Advisors (New York) New York $18.2B AUM 21.48% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $5B AUM 26.84% 1-Year Est. Return
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $187B AUM 21.7% 1-Year Est. Return

UBS Group's RNXT Position: Q2 2026 in Review

UBS Group increased its RenovoRx (RNXT) stake by 524% in Q2 2026, buying an estimated $15.9K and bringing the position to 20,820 shares worth $20.4K. The position accounts for ﹤0.01% of the portfolio, ranked #8157.

UBS Group first reported a position in RNXT in Q4 2021 and has held it in 13 quarters since. The position peaked at $66.1K in Q1 2025. 28 funds tracked by Wall St. Rank hold RNXT as of Q2 2026.

  • UBS Group held 20,820 shares of RenovoRx worth $20.4K as of Q2 2026.
  • UBS Group bought 17,482 RenovoRx shares in Q2 2026, an estimated $15.9K.
  • RenovoRx made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #8157 holding.
  • UBS Group first reported a position in RenovoRx in Q4 2021 and has held it in 13 quarters since.
  • UBS Group's RenovoRx position peaked at $66.1K in Q1 2025.
  • 28 funds tracked by Wall St. Rank held RenovoRx as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.